Disease/Infection News

RSS

Staff, students join hands outside LSTM to mark World Malaria Day

One hundred staff and students joined hands outside Liverpool School of Tropical Medicine (LSTM) today to mark World Malaria Day, each person symbolising 10,000 of the lives lost every year to malaria.

21 Apr 2010

Initial results of gallium-containing compound to treat serious infection presented at AACR 2010

Genta Incorporated today announced the presentation of initial results from the first human use of a gallium-containing compound to treat serious infection. In a patient with cystic fibrosis and a highly resistant lung infection, who has been treated over a 2-year period, high concentrations of gallium were achieved in sputum.

21 Apr 2010

A*STAR's BMRC and SIgN award grants for twelve research projects on infectious diseases and immunology

Twelve research projects on infectious diseases and immunology have been awarded grants by A*STAR's Biomedical Research Council (BMRC) and Singapore Immunology Network (SIgN) this year.

21 Apr 2010

Study identifies the source of inherent noise in HIV gene expression

New research identifies a molecular mechanism that the human immunodeficiency virus (HIV) appears to utilize for generating random fluctuations called "noise" in its gene expression.

21 Apr 2010

People around the world support anti-malaria campaigns

Congressional Malaria Champions today received over 20,000 signatures from people around the world supporting efforts to eliminate malaria. Members of local youth soccer teams and actress Molly Sims presented signatures gathered through United Against Malaria, a soccer driven anti-malaria campaign, and by World Vision's End Malaria campaign.

21 Apr 2010

Early diagnosis of varicose vein disease leads to simpler treatments and better outcomes

Varicose vein disease is an underappreciated and often misunderstood medical condition, causing many individuals to be misdiagnosed, mistreated - or ignored - resulting in needless suffering and complications from progressively worsening symptoms. Unfortunately, patients typically wait until the disease reaches a more difficult to treat and debilitating stage: they have lifestyle limiting pain, unsightly bulging veins and spider veins, leg swelling or skin ulceration.

21 Apr 2010

Test shows efficacy of avian antibodies against H5N1 and H1N1 influenza in mice

Scientists have discovered for the first time that antibodies in common eggs laid by hens vaccinated against the H5N1 virus can potentially prevent a possible H5N1 pandemic, raising the possibility that the same principle could be applied to the current H1N1 influenza pandemic.

21 Apr 2010

Roche's progress of RG7348 into Phase I clinical trial triggers $6.5M milestone payment to Ligand

Ligand Pharmaceuticals Incorporated today announced that it earned a $6.5 million payment from Roche as a result of Roche progressing RG7348 into a Phase I clinical trial for the treatment of hepatitis C viral (HCV) infection. The milestone payment arises from a 2008 collaboration and license agreement between Roche and Metabasis Therapeutics, Inc.

21 Apr 2010

New study quantifies prevalence of MRSA infections in different patient populations

A multi-center study led by a researcher at Rhode Island Hospital has determined that long-term elder care, HIV-infected and hemodialysis patients are at increased risk of carrying methicillin-resistant Staphylococcus aureus (MRSA) in their nose.

21 Apr 2010

Biomagnetics Diagnostics obtains handheld IOBS unit to detect pathogens

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced it has received its first handheld integrated optical biosensor unit from Los Alamos National Security, LLC.

21 Apr 2010

Pregnant women face increased risk of death from H1N1; early antiviral treatment associated with fewer complications

Pregnant women had a disproportionately higher risk of death due to 2009 influenza A(H1N1) in the U.S., and early antiviral treatment appeared to be associated with fewer admissions to an ICU and fewer deaths, according to a study in the April 21 issue of JAMA.

21 Apr 2010

Report details progress in fighting malaria in Africa, notes funding shortfall

Global funding for malaria reached $1.7 billion in 2009, a "ten-fold" increase since 2004, and the production of insecticide-treated nets (ITNs) worldwide rose to 150 million last year, according to a report, released Monday, from UNICEF and the Roll Back Malaria (RBM) partnership, which also highlighted the need for additional funding, Agence France-Presse reports (4/19).

21 Apr 2010

Black and Hispanic children have high rate of hospital admissions for ruptured appendix

Black children were one-third more likely than white children to be hospitalized for a ruptured appendix in 2006, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

21 Apr 2010

ZenBio awarded Phase I SBIR grant to establish novel human cell-based models of NAFLD

ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to establish novel human cell-based models of non-alcoholic fatty liver disease (NAFLD) that will be useful for basic research and as a potential drug development platform. The project stems from recent efforts at ZenBio, Inc. to develop methods for differentiating adipose tissue derived progenitor cells into hepatocyte-like cells.

21 Apr 2010

A Selection of Today's Opinions: AIDS endures; Conservatives' changing views of the individual mandate; Concerns for doctors

AIDS endures right here in the U.S.A.: our outpatient clinics are bursting at the seams, and new cases show up daily. A million domestic stories are languishing untold, but they are not the operatic tragedies we have grown used to (Dr. Abigail Zuger, 4/19).

21 Apr 2010

AMRI extends and expands research collaboration with CHDI Foundation

AMRI announced today the five year extension and expansion of its ongoing research collaboration with CHDI Foundation, Inc. (CHDI), focused on the discovery of new therapeutic agents for the treatment of Huntington's disease (HD).

20 Apr 2010

Cal/OSHA issues $101,485 in citations to Alta Bates Summit Medical Center in Oakland

The Department of Industrial Relations' Division of Occupational Safety and Health, better known as Cal/OSHA, today issued $101,485 in citations to Alta Bates Summit Medical Center in Oakland for ten violations of the state safety and health standards in connection to a life-threatening exposure of bacterial meningitis.

20 Apr 2010

Ovale malaria is two similar but distinct species that do not reproduce with each other: Research

Scientists investigating ovale malaria, a form of the disease thought to be caused by a single species of parasite, have confirmed that the parasite is actually two similar but distinct species which do not reproduce with each other, according to research published in The Journal of Infectious Diseases.

20 Apr 2010

Interim results from QLT's Phase 1b study of QLT091001 for Leber congenital amaurosis

QLT Inc. today announced interim results from the first 3 subjects enrolled in a Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber congenital amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and significant visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of visual function.

20 Apr 2010

Prevalence of scalp fungus infection among children living in metropolitan areas

Approximately 7 percent of elementary school children across the bi-state, Kansas City metropolitan area are infected with the fungus Trichophyton tonsurans (T. tonsurans), the leading cause of ringworm in the U.S., according to a new study published today in Pediatrics. This is the largest study to date aimed at defining infection prevalence of the scalp fungus in children living in a metropolitan area and has implications for children nationwide.

20 Apr 2010

Disease/Infection News

Staff, students join hands outside LSTM to mark World Malaria Day

Initial results of gallium-containing compound to treat serious infection presented at AACR 2010

A*STAR's BMRC and SIgN award grants for twelve research projects on infectious diseases and immunology

Study identifies the source of inherent noise in HIV gene expression

People around the world support anti-malaria campaigns

Early diagnosis of varicose vein disease leads to simpler treatments and better outcomes

Test shows efficacy of avian antibodies against H5N1 and H1N1 influenza in mice

Roche's progress of RG7348 into Phase I clinical trial triggers $6.5M milestone payment to Ligand

New study quantifies prevalence of MRSA infections in different patient populations

Biomagnetics Diagnostics obtains handheld IOBS unit to detect pathogens

Pregnant women face increased risk of death from H1N1; early antiviral treatment associated with fewer complications

Report details progress in fighting malaria in Africa, notes funding shortfall

Black and Hispanic children have high rate of hospital admissions for ruptured appendix

ZenBio awarded Phase I SBIR grant to establish novel human cell-based models of NAFLD

A Selection of Today's Opinions: AIDS endures; Conservatives' changing views of the individual mandate; Concerns for doctors

AMRI extends and expands research collaboration with CHDI Foundation

Cal/OSHA issues $101,485 in citations to Alta Bates Summit Medical Center in Oakland

Ovale malaria is two similar but distinct species that do not reproduce with each other: Research

Interim results from QLT's Phase 1b study of QLT091001 for Leber congenital amaurosis

Prevalence of scalp fungus infection among children living in metropolitan areas

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News